Pharma News

Researchers have discovered that a molecule in the tapeworm drug niclosamide might be able to protect against Parkinson's disease-related neuronal damage.

A legal challenge against Gilead Sciences’ (Nasdaq.

The US Food and Drug Administration has lifted the hold on clinical studies with fitusiran, including the Phase II open-label extension (OLE) study and the ATLAS Phase III program.

LONDON (Reuters) - The European drugs agency said on Friday its new headquarters in Amsterdam may not be ready by the time it has to leave London due to Brexit because the building will not be...

The Food and Drug Administration has approved Mumbai-based Lupin’s Tydemy.

Pfizer is already working to pick up market share with Inflectra, the first biosimilar to Johnson & Johnson's blockbuster immunology med Remicade, but now the company has a second copycat boas...

LONDON/FRANKFURT (Reuters) - Generic drugmaker Perrigo has decided to enter the fray for Merck KGaA’s consumer health unit, sources told Reuters, and is preparing an indicative offer for the...

At the beginning of 2017, expectations were pretty high that the pharma and biotech sector would finally see lots of mergers and acquisitions (M&As).

Despite being late to market, the collaborators hope a new indication could help boost its prospects.

Needles are usually seen as a necessary evil, but maybe they don't have to be.

Australia’s University of Wollongong (UOW) is quickly becoming a pioneer in 3D bioprinting technologies.

(New York) – Chinese authorities in Xinjiang are collecting DNA samples, fingerprints, iris scans, and blood types of all residents in the region between the age of 12 and 65, Human Rights W...